FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to the field of medicine and pharmaceutics, namely to the use of a drug for the treatment of a disorder related to alcohol consumption, including pernicious alcohol consumption, alcohol abuse, pre-alcoholism and alcoholism, where the drug includes an active ingredient, which is a compound or its pharmacologically acceptable salt selected from a group consisting of N-(3-{(1R,5S,6r)-6-ethyl-3-[(2-hydroxy-2,3-dihydro-1H-indene-2-yl)methyl]-3-azabicyclo[3.1.0]hexane-6-yl}-4-fluorophenyl)cyclopropanesulfonamide, N-(3-{(1R,5S,6r)-3-[3-(4,4-difluoro-1-methoxycyclohexyl)propyl]-6-ethyl-3-azabicyclo[3.1.0]hexane-6-yl}phenyl)cyclopropanesulfonamide and N-(3-{(1R,5S,6r)-3-[3-(4,4-difluorocyclohexyl)propyl]-6-ethyl-3-azabicyclo[3.1.0]hexane-6-yl}phenyl)cyclopropanesulfonamide.
EFFECT: invention provides for new drugs for the treatment of a disorder related to alcohol consumption.
8 cl, 4 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW DERIVATIVE OF 3-AZABICYCLO[3.1.0]HEXANE AND USE THEREOF FOR MEDICAL PURPOSES | 2014 |
|
RU2701861C1 |
| AZABICYCLO{3,1,0}HEXANE DERIVATIVES USED AS DOPAMINE RECEPTOR D3 MODULATORS | 2005 |
|
RU2434011C2 |
| AMINOPYRIDINE DERIVATIVES AND APPLICATION THEREOF AS SELECTIVE ALK-2 INHIBITORS | 2017 |
|
RU2777979C2 |
| AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS | 2022 |
|
RU2803084C1 |
| AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS | 2017 |
|
RU2747318C2 |
| HEXONE-GLUCOKINASE INHIBITOR AND ITS USE | 2020 |
|
RU2797185C2 |
| PHARMACEUTICAL COMPOUNDS | 2018 |
|
RU2767857C2 |
| PRODRUG OF THE AMINO ACID DERIVATIVE | 2017 |
|
RU2739318C2 |
| (-)-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE, ITS COMPOSITION AND USING AS INHIBITOR OF DOPAMINE REUPTAKE | 2002 |
|
RU2300522C2 |
| OXADIAZOLES AS MUSCARINIC RECEPTOR AGONISTS M AND/OR M | 2019 |
|
RU2817018C2 |
